Although the function of BMP signaling in tumorigenesis and tumor progression remains controversial, the overexpression of Noggin leads to decreased tumor size and reduced bone metastatic tumor growth in prostate cancer and lung cancer models [22, 23]. This evidence concerns the gene NOG and prostate cancer.